The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

Clalit Health Services

Status: Unknown

Conditions: Attention Deficit Hyperactivity Disorder; Enuresis

Treatments: Drug: methylphenidate

Study type: Observational

Funder types: Other

Identifiers

NCT02699528

MMC-15-0329

Details and patient eligibility

About

To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder

Full description

Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.

Enrollment: 50 estimated patients

Sex: All

Ages: 5 to 10 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• New diagnosis of attention deficit hyperactivity disorder
• History of primary nocturnal enuresis
• Normal neurological examination

Exclusion criteria

• Anatomical abnormality of the genitourinary system
• Concommitant treatment, pharmacological/behavioral for enuresis
• Concommitant diurnal enuresis